# CVM GFI #224 (Supplement to VICH GL52) Supplemental Examples For Illustrating Statistical Concepts Described in the VICH In Vivo Bioequivalence Guidance GL52 - FDA Guidance Document Source: https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-224-supplement-to-vich-gl52-supplemental-examples-for-illustrating-statistical-concepts-described-in-the-vich-in-vivo-bioequivalence-guidance-gl52/bb61941b-429e-409c-b8ce-8edfb2ecb7c4 > FDA guidance document: CVM GFI #224 (Supplement to VICH GL52) Supplemental Examples For Illustrating Statistical Concepts Described in the VICH In Vivo Bioequivalence Guidance GL52. Issue date: September 24, 2014. Get complete insights and analysis. --- ## Details - Title: CVM GFI #224 (Supplement to VICH GL52) Supplemental Examples For Illustrating Statistical Concepts Described in the VICH In Vivo Bioequivalence Guidance GL52 - Communication Type: Guidance Document - Product Type: veterinary - Office Name: Center for Veterinary Medicine - Office URL: /offices/center-for-veterinary-medicine/7e30a309-56e4-4e7a-8b8b-e07674bb07b4 - Issue Date: 2014-09-24 - Comment Close Date: 2014-11-24 - Last Changed: 2019-04-16 - Docket Number: FDA-2014-D-1352 ## Related Documents - [CVM GFI #173 Appendix for the Animal Drug Sponsor Fees Under ADUFA](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-173-appendix-for-the-animal-drug-sponsor-fees-under-adufa/14b5f2a8-7a0d-445f-bac6-f483fb21ecf9) - [CVM GFI #224 (VICH GL52) Bioequivalence: Blood Level Bioequivalence Study](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-224-vich-gl52-bioequivalence-blood-level-bioequivalence-study/7cc12568-964a-494b-8e09-40ddcb294891) - [Guidance Document for Testing Non-Articulating, 'Mechanically Locked', Modular Implant Components](https://www.globalkeysolutions.net/guidances/guidance-document/guidance-document-for-testing-non-articulating-mechanically-locked-modular-implant-components/5c304757-5bd1-4487-9c2a-9b348dad9556)